J. Read

J. Read

Gründer bei Seriosity, Inc.

73 Jahre
Health Technology
Technology Services
Finance

Profil

J.
Leighton Read
is the founder of Seriosity, Inc. (founded in 2004) where he is currently the Executive Chairman.
He was also the founder of Affymax NV (founded in 1988) where he served as the Managing Director from 1988 to 1991.
Dr. Read is also the founder of MedImmune Vaccines, Inc. Dr. Read's current job(s) include being the Executive Chairman of Global Kinetics Pty Ltd., Director of Genomatica, Inc. (since 2012), Director of Siluria Technologies, Inc. (since 2013), Director of Opal Therapeutics, Inc., Director of Bio Ventures for Global Health, Director of Beneficent Technology, Inc., Director of Allay Therapeutics, Inc., Venture Partner at Alloy Ventures, Inc. (since 2001),.
Trustee at Santa Fe Institute of Science, Trustee at University of California, Berkeley Foundation, and Venture Partner at Brandon Capital Partners Pty Ltd.
Dr. Read's former job(s) include being the Chief Executive Officer of Avidia, Inc. (from 2003 to 2005), Co-Chief Executive Officer & Director of BioPlus Acquisition Corp., Director of CV Therapeutics, Inc., Director of Apptera, Inc., Independent Director of Alexza Pharmaceuticals, Inc. (from 2004 to 2016), Director of Cambrios Technologies Corp., Director of EBR Systems, Inc., Director of AnaptysBio, Inc., Director-Emeritus of Institute for Systems Biology, Non-Executive Director of GI Therapies Pty Ltd., and Director of Okogen, Inc. Dr. Read's education includes an undergraduate degree from Rice University (conferred in 1973) and a doctorate degree from Texas University of Health Center at San Antonio (conferred in 1976).

Aktive Positionen von J. Read

UnternehmenPositionBeginn
Private Equity Investor 01.10.2001
Direktor/Vorstandsmitglied 01.07.2007
Gründer 09.08.2009
Direktor/Vorstandsmitglied 21.10.2010
Bio Ventures for Global Health Direktor/Vorstandsmitglied -
Opal Therapeutics, Inc. Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
░░░░░░ ░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░ -
Alle aktiven Positionen von J. Read

Ehemalige bekannte Positionen von J. Read

UnternehmenPositionEnde
░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von J. Read im Detail an

Ausbildung von J. Read

Rice University Undergraduate Degree
Texas University of Health Center at San Antonio Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von J. Read im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

27

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
EBR SYSTEMS, INC.

Health Technology

ANAPTYSBIO, INC.

Health Technology

Private Unternehmen23

Health Technology

Health Technology

Finance

Health Technology

Technology Services

Health Technology

Electronic Technology

Technology Services

Health Technology

Process Industries

Opal Therapeutics, Inc.

Affymax NV

Health Technology

Commercial Services

Bio Ventures for Global Health

Commercial Services

Miscellaneous

Finance

Health Technology

Technology Services

Health Technology

Commercial Services

Finance

Technology Services

Sehen Sie sich die Unternehmensverbindungen an